StockDriftsStockDriftsTop 3 Kpcb Xv Associates, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RAPT | Rapt Therapeutics, Inc. | 43.54% | 648.5K | $16K | new | — | 2022-09-30 | |
| TWLO | Twilio Inc. | 36.66% | 190.0K | $13K | new | — | 2022-09-30 | |
| ATRA | Atara Biotherapeutics, Inc. | 19.79% | 1.88M | $7K | new | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Kpcb Xv Associates, Llc reports $35.84K in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are RAPT (43.5%), TWLO (36.7%) and ATRA (19.8%). Figures reflect the Q3 2022 filing.
Sign up free to track Kpcb Xv Associates, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Kpcb Xv Associates, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1547838). View Kpcb Xv Associates, Llc’s 13F filings on SEC